Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

drugsDecember 18, 2018

Tag: Buprenorphine-Naloxone , opioid , QALYs , clinical trial

PharmaSources Customer Service